Reading in to the Suspension, they must just be working through the final stages of the financing. If Shougang were not interested we would know by now.Hopefully they can get there S#*% together by next friday.Heres hoping
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling